Organon & Co | OGN - Net Income

Stock Price
6.35
Daily Change
0.02 0.32%
Monthly
-12.77%
Yearly
-58.62%
Q1 Forecast
6.16

Organon & Co reported $160M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Novartis USD 3.93B 113M Sep/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Pharma Mar EUR 59.66M 63.76M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025